Evidence map›Paper›PMID 41798409›Full record

ArticleCureus2026

Cutaneous Metastatic Lesions as a Rare Manifestation of Colorectal Adenocarcinoma: A Case Report.

Jeevan Rivera-Díaz, Sofía Laguna Rocafort, Jose Rabelo-Cartagena

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jeevan Rivera-DíazSchool of Medicine, Universidad Central del Caribe, Bayamón, PRI.
Sofía Laguna RocafortSchool of Medicine, Universidad Central del Caribe, Bayamón, PRI.
Jose Rabelo-CartagenaDermatology, VA Caribbean Healthcare System, San Juan, PRI.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous metastasis is an uncommon manifestation of colorectal cancer, usually occurring in an advanced disease state. We present a case of a 93-year-old man with a history of multiple non-melanoma skin cancers who was previously diagnosed with primary adenocarcinoma of the colon. The patient presented with three nodules on his upper back that developed over a few weeks. Physical examination revealed two erythematous, firm, dome-shaped nodules without discharge, and a third, smaller, flesh-colored, and non-ulcerated lesion. No palpable regional lymphadenopathy was noted. Two punch biopsies were performed on representative lesions. Histopathologic analysis demonstrated irregular glandular structures infiltrating the dermis, composed of atypical mucin-producing columnar cells with abundant eosinophilic cytoplasm and extracellular mucin deposits interspersed among collagen fibers. Immunohistochemical staining was positive for CDX2, CK20, and SATB2, and negative for CK7, findings consistent with metastatic colorectal adenocarcinoma. The patient's clinical course was consistent with advanced disease, and he passed away approximately three months after the onset of cutaneous lesions. This case highlights the importance of recognizing cutaneous metastases as a potential indicator of systemic spread in patients with a history of colorectal cancer. Prompt dermatologic evaluation, histopathologic confirmation, and multidisciplinary coordination are crucial for accurate staging and effective care. Greater awareness and standardized guidelines are necessary to enhance the diagnostic approach and management of this rare yet clinically significant manifestation.

Indexed as

cdx2ck20colorectal adenocarcinomacolorectal cancercutaneous metastasessatb2skin lesionskin metastasis

Identifiers

PMID41798409
PMCPMC12962041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.